19 May 2013
Keywords: encouraging, early, findings, transgene, hcv, vacc, french
Article | 26 May 2008
French biotechnology firm Transgene SA has reported positive preliminary results from an ongoing Phase I trial of its therapeutic vaccine ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 May 2008
17 May 2013
© 2013 thepharmaletter.com